INDOCO REMEDIES LTD. - 532612 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Intimation under regulation 30 of SEBI (LODR)Regulations,2015-Proceeding of Postal Ballot28-06-2024
28-06-2024
INDOCO REMEDIES LTD. - 532612 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Disclosure of voting results of Postal Ballot pursuant to regulation 44 of the SEBI(LODR)Regulations,2015 alongwith Scrutinizers Report.28-06-2024
INDOCO REMEDIES LTD. - 532612 - Closure of Trading Window
Trading Window for trading/dealing in Equity Shares of the Company will remain closed from Monday, 01, July ,2024 until 48 hours after declaration of Standalone and Consolidated Financial Results of the Company for the quarter ended 30-06-202428-06-2024
INDOCO REMEDIES LTD. - 532612 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Enclosed herewith in Annexure A the details of the notice as per Rule 99(1) in Form GST ASMT-10 received from the Goods and Service Tax (GST) Authority.19-06-2024
Indoco Remedies - U.S. To Drive Growth: Nirmal Bang
The company acquired a 85% stake in FPP for $4 million to enhance its front-end marketing and distribution strength in the U.S.13-06-2024
INDOCO REMEDIES LTD. - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others10-06-2024
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Investor Presentation
Enclosed a copy of Investor Presentation of the Company that will be shared with the various investors/Analysts.10-06-2024
INDOCO REMEDIES LTD. - 532612 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others10-06-2024
USFDA Approves Indoco Remedies' Generic Diabetes Drug
USFDA grants approval to Indoco Remedies for generic diabetes drug, Canagliflozin and Metformin Hydrochloride tablets.06-06-2024
INDOCO REMEDIES LTD. - 532612 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Indoco Remedies receives tentative ANDA approval from USFDA for Canagliflozin and Metformin Hydrochloride Tablets06-06-2024